Intramolecular interactions and regulation of cofactor binding by the four repressive elements in the caspase recruitment domain-containing protein 11 (CARD11) inhibitory Domain

Journal of Biological Chemistry

Volumn 291, Issue 16, 2016, Pages 8338-8348

  Jattani, Rakhi P ^a   Tritapoe, Julia M ^a   Pomerantz, Joel L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINS; ONCOLOGY; SIGNALING;

ADAPTIVE IMMUNE RESPONSE; ANTIGEN RECEPTORS; ASSOCIATED GAIN; COFACTOR BINDING; DIFFUSE LARGE B-CELL LYMPHOMA; DOMAIN-CONTAINING PROTEINS; INHIBITORY DOMAINS; INTRAMOLECULAR INTERACTIONS;

CELL SIGNALING;

AMINO ACID; CARD11 PROTEIN; CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 10; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; BCL10 PROTEIN, HUMAN; CARD11 PROTEIN, HUMAN; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; GUANYLATE CYCLASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR PROTEIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; GAIN OF FUNCTION MUTATION; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN COFACTOR BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN REPRESSIVE ELEMENT; PROTEIN STRUCTURE; PROTEIN TARGETING; SIGNAL TRANSDUCTION; AMINO ACID SUBSTITUTION; DIFFUSE LARGE B CELL LYMPHOMA; GENETICS; HEK293 CELL LINE; JURKAT CELL LINE; METABOLISM; MUTATION; PROTEIN TERTIARY STRUCTURE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SUBSTITUTION; CARD SIGNALING ADAPTOR PROTEINS; GUANYLATE CYCLASE; HEK293 CELLS; HUMANS; JURKAT CELLS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MUTATION; NEOPLASM PROTEINS; NF-KAPPA B; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

EID: 84964969105     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.717322     Document Type: Article

References (31)

1. Schulze-Luehrmann, J., and Ghosh, S. (2006) Antigen-receptor signaling to nuclear factor κB. Immunity 25, 701-715
2. Gaide, O., Favier, B., Legler, D. F., Bonnet, D., Brissoni, B., Valitutti, S., Bron, C., Tschopp, J., and Thome, M. (2002) CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-κB activation. Nat. Immunol. 3, 836-843
3. Wang, D., You, Y., Case, S. M., McAllister-Lucas, L. M., Wang, L., DiStefano, P. S., Nuñez, G., Bertin, J., and Lin, X. (2002) A requirement for CARMA1 in TCR-induced NF-κB activation. Nat. Immunol. 3, 830-835
4. Pomerantz, J. L., Denny, E. M., and Baltimore, D. (2002) CARD11 mediates factor-specific activation of NF-κB by the T cell receptor complex. EMBO J. 21, 5184-5194
5. Hara, H., Wada, T., Bakal, C., Kozieradzki, I., Suzuki, S., Suzuki, N., Nghiem, M., Griffiths, E. K., Krawczyk, C., Bauer, B., D'Acquisto, F., Ghosh, S., Yeh, W. C., Baier, G., Rottapel, R., and Penninger, J. M. (2003) The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 18, 763-775
6. Jun, J. E., Wilson, L. E., Vinuesa, C. G., Lesage, S., Blery, M., Miosge, L. A., Cook, M. C., Kucharska, E. M., Hara, H., Penninger, J. M., Domashenz, H., Hong, N. A., Glynne, R. J., Nelms, K. A., and Goodnow, C. C. (2003) Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 18, 751-762
7. Egawa, T., Albrecht, B., Favier, B., Sunshine, M. J., Mirchandani, K., O'Brien, W., Thome, M., and Littman, D. R. (2003) Requirement for CARMA1 in antigen receptor-induced NF-κB activation and lymphocyte proliferation. Curr. Biol. 13, 1252-1258
8. Newton, K., and Dixit, V. M. (2003) Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes. Curr. Biol. 13, 1247-1251
9. Stepensky, P., Keller, B., Buchta, M., Kienzler, A. K., Elpeleg, O., Somech, R., Cohen, S., Shachar, I., Miosge, L. A., Schlesier, M., Fuchs, I., Enders, A., Eibel, H., Grimbacher, B., and Warnatz, K. (2013) Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects. J. Allergy Clin. Immunol. 131, 477-485 e471
10. Greil, J., Rausch, T., Giese, T., Bandapalli, O. R., Daniel, V., Bekeredjian-Ding, I., Stütz, A. M., Drees, C., Roth, S., Ruland, J., Korbel, J. O., and Kulozik, A. E. (2013) Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiency. J. Allergy Clin. Immunol. 131, 1376-1383
11. McCully, R. R., and Pomerantz, J. L. (2008) The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-κB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association. Mol. Cell. Biol. 28, 5668-5686
12. Matsumoto, R., Wang, D., Blonska, M., Li, H., Kobayashi, M., Pappu, B., Chen, Y., Wang, D., and Lin, X. (2005) Phosphorylation of CARMA1 plays a critical role in T cell receptor-mediated NF-κB activation. Immunity 23, 575-585
13. Sommer, K., Guo, B., Pomerantz, J. L., Bandaranayake, A. D., Moreno-García, M. E., Ovechkina, Y. L., and Rawlings, D. J. (2005) Phosphorylation of the CARMA1 linker controls NF-κB activation. Immunity 23, 561-574
14. Wegener, E., Oeckinghaus, A., Papadopoulou, N., Lavitas, L., Schmidt-Supprian, M., Ferch, U., Mak, T. W., Ruland, J., Heissmeyer, V., and Krappmann, D. (2006) Essential role for IκB kinase β in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation. Mol. Cell 23, 13-23
15. Shinohara, H., Maeda, S., Watarai, H., and Kurosaki, T. (2007) IκB kinase β-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells. J. Exp. Med. 204, 3285-3293
16. Thome, M., Charton, J. E., Pelzer, C., and Hailfinger, S. (2010) Antigen receptor signaling to NF-κB via CARMA1, BCL10, and MALT1. Cold Spring Harb. Perspect. Biol. 2, a003004
17. Lim, K. H., Yang, Y., and Staudt, L. M. (2012) Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies. Immunol. Rev. 246, 359-378
18. Rui, L., Schmitz, R., Ceribelli, M., and Staudt, L. M. (2011) Malignant pirates of the immune system. Nat. Immunol. 12, 933-940
19. Davis, R. E., Brown, K. D., Siebenlist, U., and Staudt, L. M. (2001) Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 194, 1861-1874
20. Ngo, V. N., Davis, R. E., Lamy, L., Yu, X., Zhao, H., Lenz, G., Lam, L. T., Dave, S., Yang, L., Powell, J., and Staudt, L. M. (2006) A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441, 106-110
21. Lenz, G., Davis, R. E., Ngo, V. N., Lam, L., George, T. C., Wright, G. W., Dave, S. S., Zhao, H., Xu, W., Rosenwald, A., Ott, G., Muller-Hermelink, H. K., Gascoyne, R. D., Connors, J. M., Rimsza, L. M., et al. (2008) Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676-1679
22. Compagno, M., Lim, W. K., Grunn, A., Nandula, S. V., Brahmachary, M., Shen, Q., Bertoni, F., Ponzoni, M., Scandurra, M., Califano, A., Bhagat, G., Chadburn, A., Dalla-Favera, R., and Pasqualucci, L. (2009) Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma. Nature 459, 717-721
23. Lohr, J. G., Stojanov, P., Lawrence, M. S., Auclair, D., Chapuy, B., Sougnez, C., Cruz-Gordillo, P., Knoechel, B., Asmann, Y. W., Slager, S. L., Novak, A. J., Dogan, A., Ansell, S. M., Link, B. K., Zou, L., et al. (2012) Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc. Natl. Acad. Sci. U.S.A. 109, 3879-3884
24. Bu, R., Bavi, P., Abubaker, J., Jehan, Z., Al-Haqawi, W., Ajarim, D., Al-Dayel, F., Uddin, S., and Al-Kuraya, K. S. (2012) Role of NF-κB regulators-TNFAIP3 and CARD11 in Middle Eastern diffuse large B cell lymphoma. Leuk. Lymphoma 53, 1971-1977
25. Dong, G., Chanudet, E., Zeng, N., Appert, A., Chen, Y. W., Au, W. Y., Hamoudi, R. A., Watkins, A. J., Ye, H., Liu, H., Gao, Z., Chuang, S. S., Srivastava, G., and Du, M. Q. (2011) A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma. Clin. Cancer Res. 17, 1440-1451
26. Lamason, R. L., McCully, R. R., Lew, S. M., and Pomerantz, J. L. (2010) Oncogenic CARD11 mutations induce hyperactive signaling by disrupting autoinhibition by the PKC-responsive inhibitory domain. Biochemistry 49, 8240-8250
27. Chan, W., Schaffer, T. B., and Pomerantz, J. L. (2013) A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival. Mol. Cell. Biol. 33, 429-443
28. Jattani, R. P., Tritapoe, J. M., and Pomerantz, J. L. (2016) Cooperative control of caspase recruitment domain-containing protein 11 (CARD11) signaling by an unusual array of redundant repressive elements. J. Biol. Chem. 291, 8324-8336
29. Lamason, R. L., Kupfer, A., and Pomerantz, J. L. (2010) The dynamic distribution of CARD11 at the immunological synapse is regulated by the inhibitor kinesin GAKIN. Mol. Cell 40, 798-809
30. Hara, H., Yokosuka, T., Hirakawa, H., Ishihara, C., Yasukawa, S., Yamazaki, M., Koseki, H., Yoshida, H., and Saito, T. (2015) Clustering of CARMA1 through SH3-GUK domain interactions is required for its activation of NF-κB signalling. Nat. Commun. 6, 5555
31. Wu, C. J., and Ashwell, J. D. (2008) NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-κB activation. Proc. Natl. Acad. Sci. U.S.A. 105, 3023-3028